Efficacy and Safety of TV-1380 as Treatment for Facilitation of Abstinence in Cocaine-Dependent Subjects

NCT01887366 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

208

Enrollment

INDUSTRY

Sponsor class

Conditions

Cocaine Addiction

Interventions

DRUG: TV-1380 150 mg
DRUG: TV-1380 300 mg
DRUG: Placebo

Sponsor

Teva Branded Pharmaceutical Products R&D, Inc.